Conditions: Diabetes Diabetes Mellitus, Type 2
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 506
Healthy volunteers: no

Brief summary:
This trial is conducted globally. The aim of this trial is to compare efficacy and safety of insulin degludec/liraglutide (IDegLira) versus basal-bolus therapy in combination with metformin in subjects with type 2 diabetes mellitus.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: insulin degludec/liraglutide intervention 2: insulin glargine intervention 3: insulin aspart
Intervention descriptions: intervention 1: Once daily injected s.c./subcutaneously (under the skin) in combination with metformin. intervention 2: Once daily injected s.c./subcutaneously (under the skin) in combination with metformin. intervention 3: Injected s.c./subcutaneously (under the skin) before each main meal.

Protocol document: